Abstract:Tumors pose a significant threat to human health, and their occurrence and fatality rates are on the rise each year. Accurate tumor diagnosis is crucial in preventing untimely treatment and late-stage metastasis, thereby reducing mortality. To address this, we have developed a novel type of hybrid nanogels called γ-Fe2O3@PNIPAM/PAm/CTS, which contain iron oxide nanoparticles and poly(N-isopropyl acrylamide)/poly(acrylamide)/chitosan. The rational for this study relies on the concept that thermosensitive PNIPAM has the ability to contract when exposed to the elevated temperature conditions found within tumors. This contraction leads to a dense clustering of the high-loading γ-Fe2O3 nanoparticles within the nanogel, thus greatly enhancing the capabilities of MRI imaging. Additionally, the amino groups in chitosan on the particle surface can be converted into ammonium salts under mildly acidic conditions, allowing for an increase in the charge of the nanogel specifically at the slightly acidic tumor site. Consequently, it promotes the phagocytosis of tumor cells and effectively enhances the accumulation and retention of nanogels at the tumor site. The synthesis of the hybrid nanogels involves a surfactant-free emulsion copolymerization process, where vinyl-modified γ-Fe2O3 superparamagnetic nanoparticles are copolymerized with the monomers in the presence of chitosan. We have optimized various reaction parameters to achieve a high loading content of the superparamagnetic nanoparticles, reaching up to 60%. The achieved r2 value of 517.74 mM-1S-1 significantly surpasses that of the clinical imaging contrast agent Resovist (approximately 151 mM-1S-1). To assess the performance of these magnetic nanogels, we conducted experiments using Cal27 oral tumors and 4T1 breast tumors in animal models. The nanogels exhibited temperature- and pH-sensitivity, enabling magnetic targeting and enhancing diagnosis through MRI imaging. The results demonstrated the potential of these hybrid nanogels as contrast agents for magnetic targeting in biomedical applications.

Porous Silicon-Superparamagnetic Iron Oxide Complexes And Impact On Negative Contrast Enhancement In Mri

A Sub-50-nm Monosized Superparamagnetic Fe3O4@SiO2 T2-weighted MRI Contrast Agent: Highly Reproducible Synthesis of Uniform Single-Loaded Core-Shell Nanostructures.

Magnetic Resonance Imaging Contrast Agent: Crgd-Ferric Oxide Nanometer Particle and Its Role in the Diagnosis of Tumor

Blocked-micropores, surface functionalized, bio-compatible and silica-coated iron oxide nanocomposites as advanced MRI contrast agent

Positive Contrast Imaging of SPIO Nanoparticles

Liposomes Loaded with Hydrophobic Iron Oxide Nanoparticles: Suitable T₂ Contrast Agents for MRI

One-pot Facile Synthesis of PEGylated Superparamagnetic Iron Oxide Nanoparticles for MRI Contrast Enhancement.

Geometrically confined ultrasmall gadolinium oxide nanoparticles boost the T(1) contrast ability.

Amphiphilic dextran/magnetite nanocomposites as magnetic resonance imaging probes

Succinylated Heparin Monolayer Coating Vastly Increases Superparamagnetic Iron Oxide Nanoparticle T-2 Proton Relaxivity

Enhancing MRI imaging through high loading of superparamagnetic nanogels with high sensitivity to the tumor environment

Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging.

Enhancing organ and vascular contrast in preclinical ultra-low field MRI using superparamagnetic iron oxide nanoparticles

For Better or Worse, Iron Overload by Superparamagnetic Iron Oxide Nanoparticles as a MRI Contrast Agent for Chronic Liver Diseases

Hydrothermal synthesis of a highly sensitive T2-weigthed MRI contrast agent: zinc-doped superparamagnetic iron oxide nanocrystals.

TGase-induced intracellular aggregation of Fe3O4 nanoparticles for increased retention and enhanced T2 MRI

Superparamagnetic Iron Oxide Nanoparticle-Embedded Encapsulated Microbubbles As Dual Contrast Agents of Magnetic Resonance and Ultrasound Imaging.

Polymer-Coated Superparamagnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Toxicity Evaluation for MRI in Mice

Study of dextran-coated superparamagnetic iron oxides nanoparticles as MRI constrast agent

Biocompatible Low-Retention Superparamagnetic Iron Oxide Nanoclusters As Contrast Agents for Magnetic Resonance Imaging of Liver Tumor

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.